Do cefepime and cefixime cover the same bacterial organisms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, cefepime and cefixime do NOT cover the same organisms

Cefepime and cefixime have fundamentally different antimicrobial spectra and clinical applications. While both are cephalosporins, cefepime is a fourth-generation parenteral agent with broad gram-negative coverage including Pseudomonas aeruginosa, whereas cefixime is a third-generation oral agent that lacks anti-pseudomonal activity.

Key Differences in Organism Coverage

Cefepime (Fourth-Generation, IV)

According to FDA labeling, cefepime demonstrates activity against 1:

Gram-negative organisms:

  • Pseudomonas aeruginosa (critical difference)
  • Enterobacter spp
  • E. coli
  • Klebsiella pneumoniae
  • Proteus mirabilis
  • Extended coverage against AmpC-producing organisms 2, 3

Gram-positive organisms:

  • Methicillin-susceptible Staphylococcus aureus (MSSA)
  • Streptococcus pneumoniae
  • Streptococcus pyogenes
  • Viridans group streptococci

Notable resistance: Enterococci, MRSA, and Stenotrophomonas maltophilia 1

Cefixime (Third-Generation, Oral)

Cefixime has a narrower spectrum 4:

Gram-negative organisms:

  • E. coli
  • Klebsiella spp
  • Proteus mirabilis
  • Haemophilus influenzae
  • Moraxella catarrhalis
  • NO activity against Pseudomonas aeruginosa (critical difference)

Gram-positive organisms:

  • Streptococcus pyogenes
  • Streptococcus pneumoniae
  • Limited activity against staphylococci

Clinical Application Differences

When to Use Cefepime

Multiple guidelines recommend cefepime for 5, 2, 6:

  • Febrile neutropenia (empiric monotherapy)
  • Hospital-acquired infections requiring anti-pseudomonal coverage
  • Severe intra-abdominal infections (with metronidazole for anaerobes) 2, 3
  • Healthcare-associated infections with risk of resistant gram-negatives
  • Empyema requiring broad coverage 7

When to Use Cefixime

Cefixime is appropriate for 4:

  • Uncomplicated gonorrhea (though resistance emerging) 8, 9
  • Uncomplicated urinary tract infections
  • Acute otitis media in children
  • Upper respiratory tract infections (pharyngitis, tonsillitis)
  • Community-acquired infections without risk of Pseudomonas

Critical Clinical Pitfalls

Do not substitute cefixime for cefepime when:

  • Anti-pseudomonal coverage is required
  • Treating hospital-acquired infections
  • Managing febrile neutropenia
  • Treating severe infections requiring parenteral therapy
  • AmpC-producing organisms are suspected

The route of administration matters: Cefepime is IV/IM only; cefixime is oral only. This fundamentally limits their interchangeability regardless of spectrum 1, 4.

Resistance Considerations

Cefepime maintains activity against many organisms resistant to third-generation cephalosporins due to its low affinity for chromosomally-encoded beta-lactamases and resistance to AmpC induction 1, 10. Cefixime lacks this advantage and has documented increasing resistance among E. coli and N. gonorrhoeae 8, 9.

Bottom line: These are not interchangeable agents. Cefepime provides hospital-grade, broad-spectrum coverage including Pseudomonas, while cefixime is an oral agent for community-acquired infections without anti-pseudomonal activity.

References

Research

Cefepime: a fourth-generation parenteral cephalosporin.

The Annals of pharmacotherapy, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.